|
(Circulation. 2006;114:119-125.)
© 2006 American Heart Association, Inc.
Epidemiology |
From the Division of Cardiovascular Disease and Internal Medicine (Y.M., M.E.B., B.J.G., W.P.A., J.B.S., T.S.M.T.) and Section of Biostatistics (S.S.C, K.R.B.), Mayo Clinic, Rochester, Minn.
Correspondence to Dr Teresa S.M. Tsang, 200 First St SW, Rochester, MN 55905. E-mail tsang.teresa{at}mayo.edu
Received October 13, 2005; revision received May 7, 2006; accepted May 12, 2006.
Background Limited data exist on trends in incidence of atrial fibrillation (AF). We assessed the community-based trends in AF incidence for 1980 to 2000 and provided prevalence projections to 2050.
Methods and Results The adult residents of Olmsted County, Minnesota, who had ECG-confirmed first AF in the period 1980 to 2000 (n=4618) were identified. Trends in age-adjusted incidence were determined and used to construct model-based prevalence estimates. The age- and sex-adjusted incidence of AF per 1000 person-years was 3.04 (95% CI, 2.78 to 3.31) in 1980 and 3.68 (95% CI, 3.42 to 3.95) in 2000. According to Poisson regression with adjustment for age and sex, incidence of AF increased significantly (P=0.014), with a relative increase of 12.6% (95% CI, 2.1 to 23.1) over 21 years. The increase in age-adjusted AF incidence did not differ between men and women (P=0.84). According to the US population projections by the US Census Bureau, the number of persons with AF is projected to be 12.1 million by 2050, assuming no further increase in age-adjusted incidence of AF, but 15.9 million if the increase in incidence continues.
Conclusions The age-adjusted incidence of AF increased significantly in Olmsted County during 1980 to 2000. Whether or not this rate of increase continues, the projected number of persons with AF for the United States will exceed 10 million by 2050, underscoring the urgent need for primary prevention strategies against AF development.
Related Article:
This article has been cited by other articles:
|
G. A. Nichols, K. Reinier, and S. S. Chugh Independent Contribution of Diabetes to Increased Prevalence and Incidence of Atrial Fibrillation Diabetes Care, October 1, 2009; 32(10): 1851 - 1856. [Abstract] [Full Text] [PDF] |
||||
|
J. E. Freedman and B. J. Gersh New Therapies for Stroke Prevention in Atrial Fibrillation: The Long Road to Enhanced Efficacy Circulation, September 22, 2009; 120(12): 1024 - 1026. [Full Text] [PDF] |
||||
|
P. S. Chan, B. K. Nallamothu, and H. Oral Amiodarone or dronedarone for atrial fibrillation: too early to know the winner? J. Am. Coll. Cardiol., September 15, 2009; 54(12): 1096 - 1098. [Full Text] [PDF] |
||||
|
C. Patel, G.-X. Yan, and P. R. Kowey Dronedarone Circulation, August 18, 2009; 120(7): 636 - 644. [Abstract] [Full Text] [PDF] |
||||
|
C. Gemein, P. Schauerte, N. Hatam, O. R. Rana, E. Saygili, C. Meyer, C. Eickholt, M. Schmid, C. Knackstedt, M. Zarse, et al. Targeting of cardiac autonomic plexus for modulation of intracardiac neural tone Europace, August 1, 2009; 11(8): 1090 - 1096. [Abstract] [Full Text] [PDF] |
||||
|
D. E. Singer, Y. Chang, M. C. Fang, L. H. Borowsky, N. K. Pomernacki, N. Udaltsova, and A. S. Go Should Patient Characteristics Influence Target Anticoagulation Intensity for Stroke Prevention in Nonvalvular Atrial Fibrillation?: The ATRIA Study Circ Cardiovasc Qual Outcomes, July 1, 2009; 2(4): 297 - 304. [Abstract] [Full Text] [PDF] |
||||
|
P. Kirchhof, J. Bax, C. Blomstrom-Lundquist, H. Calkins, A. J. Camm, R. Cappato, F. Cosio, H. Crijns, H.-C. Diener, A. Goette, et al. Early and comprehensive management of atrial fibrillation: Proceedings from the 2nd AFNET/EHRA consensus conference on atrial fibrillation entitled 'research perspectives in atrial fibrillation' Europace, July 1, 2009; 11(7): 860 - 885. [Full Text] [PDF] |
||||
|
P. Kirchhof, J. Bax, C. Blomstrom-Lundquist, H. Calkins, A. John Camm, R. Cappato, F. Cosio, H. Crijns, H.-C. Diener, A. Goette, et al. Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF' Eur. Heart J., June 17, 2009; (2009) ehp235v1. [Abstract] [Full Text] [PDF] |
||||
|
E. Anter, M. Jessup, and D. J. Callans Atrial Fibrillation and Heart Failure: Treatment Considerations for a Dual Epidemic Circulation, May 12, 2009; 119(18): 2516 - 2525. [Full Text] [PDF] |
||||
|
J. Schmitt, G. Duray, B. J. Gersh, and S. H. Hohnloser Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications Eur. Heart J., May 1, 2009; 30(9): 1038 - 1045. [Abstract] [Full Text] [PDF] |
||||
|
A. Rosengren, P. J. Hauptman, G. Lappas, L. Olsson, L. Wilhelmsen, and K. Swedberg Big men and atrial fibrillation: effects of body size and weight gain on risk of atrial fibrillation in men Eur. Heart J., May 1, 2009; 30(9): 1113 - 1120. [Abstract] [Full Text] [PDF] |
||||
|
M. H Kim, D. Klingman, J. Lin, P. Pathak, and D. S Battleman Cost of Hospital Admission for Antiarrhythmic Drug Initiation in Atrial Fibrillation Ann. Pharmacother., May 1, 2009; 43(5): 840 - 848. [Abstract] [Full Text] [PDF] |
||||
|
D. Conen, U. B. Tedrow, B. A. Koplan, R. J. Glynn, J. E. Buring, and C. M. Albert Influence of Systolic and Diastolic Blood Pressure on the Risk of Incident Atrial Fibrillation in Women Circulation, April 28, 2009; 119(16): 2146 - 2152. [Abstract] [Full Text] [PDF] |
||||
|
S. Kaab, D. Darbar, C. van Noord, J. Dupuis, A. Pfeufer, C. Newton-Cheh, R. Schnabel, S. Makino, M. F. Sinner, P. J. Kannankeril, et al. Large scale replication and meta-analysis of variants on chromosome 4q25 associated with atrial fibrillation Eur. Heart J., April 1, 2009; 30(7): 813 - 819. [Abstract] [Full Text] [PDF] |
||||
|
D. R. Holmes Jr, K. H. Monahan, and D. Packer Pulmonary Vein Stenosis Complicating Ablation for Atrial Fibrillation: Clinical Spectrum and Interventional Considerations J. Am. Coll. Cardiol. Intv., April 1, 2009; 2(4): 267 - 276. [Abstract] [Full Text] [PDF] |
||||
|
E. Beyer, R. Lee, and B.-K. Lam Point: Minimally invasive bipolar radiofrequency ablation of lone atrial fibrillation: early multicenter results. J. Thorac. Cardiovasc. Surg., March 1, 2009; 137(3): 521 - 526. [Abstract] [Full Text] [PDF] |
||||
|
E. J. Benjamin, P.-S. Chen, D. E. Bild, A. M. Mascette, C. M. Albert, A. Alonso, H. Calkins, S. J. Connolly, A. B. Curtis, D. Darbar, et al. Prevention of Atrial Fibrillation: Report From a National Heart, Lung, and Blood Institute Workshop Circulation, February 3, 2009; 119(4): 606 - 618. [Abstract] [Full Text] [PDF] |
||||
|
A. H. Friedlander, T. T. Yoshikawa, D. S. Chang, Z. Feliciano, and C. Scully Atrial Fibrillation: Pathogenesis, Medical-Surgical Management and Dental Implications J Am Dent Assoc, February 1, 2009; 140(2): 167 - 177. [Abstract] [Full Text] [PDF] |
||||
|
WRITING GROUP MEMBERS, D. Lloyd-Jones, R. Adams, M. Carnethon, G. De Simone, T. B. Ferguson, K. Flegal, E. Ford, K. Furie, A. Go, et al. Heart Disease and Stroke Statistics--2009 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation, January 27, 2009; 119(3): e21 - e181. [Full Text] [PDF] |
||||
|
A. J. Camm, P. Kirchhof, G. Y.H. Lip, I. Savelieva, and S. Ernst CHAPTER 29 Atrial Fibrillation ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF] |
||||
|
A. Bajpai, I. Savelieva, and A. J. Camm Treatment of atrial fibrillation Br. Med. Bull., December 5, 2008; (2008) ldn046v1. [Abstract] [Full Text] [PDF] |
||||
|
K. Wachtell, R. B. Devereux, P. A. Lyle, P. M. Okin, and E. Gerdts The left atrium, atrial fibrillation, and the risk of stroke in hypertensive patients with left ventricular hypertrophy Therapeutic Advances in Cardiovascular Disease, December 1, 2008; 2(6): 507 - 513. [Abstract] [PDF] |
||||
|
A. A. Alsheikh-Ali and N.A. M. Estes III Anticoagulation Control in Atrial Fibrillation: Optimizing Risks and Benefits Circ Cardiovasc Qual Outcomes, November 1, 2008; 1(2): 72 - 73. [Full Text] [PDF] |
||||
|
M. Banach, G. Mariscalco, M. Ugurlucan, D. P. Mikhailidis, M. Barylski, and J. Rysz The significance of preoperative atrial fibrillation in patients undergoing cardiac surgery: preoperative atrial fibrillation--still underestimated opponent Europace, November 1, 2008; 10(11): 1266 - 1270. [Abstract] [Full Text] [PDF] |
||||
|
H. R. Halperin and S. Nazarian Damage Assessment After Ablation: Role of Cardiovascular Magnetic Resonance J. Am. Coll. Cardiol., October 7, 2008; 52(15): 1272 - 1273. [Full Text] [PDF] |
||||
|
D. E. Singer, G. W. Albers, J. E. Dalen, M. C. Fang, A. S. Go, J. L. Halperin, G. Y. H. Lip, and W. J. Manning Antithrombotic Therapy in Atrial Fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 546S - 592S. [Abstract] [Full Text] [PDF] |
||||
|
G. Y H Lip Don't add aspirin for associated stable vascular disease in a patient with atrial fibrillation receiving anticoagulation BMJ, March 15, 2008; 336(7644): 614 - 615. [Full Text] [PDF] |
||||
|
H. Watanabe, N. Tanabe, T. Watanabe, D. Darbar, D. M. Roden, S. Sasaki, and Y. Aizawa Metabolic Syndrome and Risk of Development of Atrial Fibrillation: The Niigata Preventive Medicine Study Circulation, March 11, 2008; 117(10): 1255 - 1260. [Abstract] [Full Text] [PDF] |
||||
|
N.A. M. Estes III, J. L. Halperin, H. Calkins, M. D. Ezekowitz, P. Gitman, A. S. Go, R. L. McNamara, J. V. Messer, J. L. Ritchie, S. J.W. Romeo, et al. ACC/AHA/Physician Consortium 2008 Clinical Performance Measures for Adults With Nonvalvular Atrial Fibrillation or Atrial Flutter: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and the Physician Consortium for Performance Improvement (Writing Committee to Develop Clinical Performance Measures for Atrial Fibrillation) Developed in Collaboration With the Heart Rhythm Society J. Am. Coll. Cardiol., February 26, 2008; 51(8): 865 - 884. [Full Text] [PDF] |
||||
|
N. A. M. Estes III, J. L. Halperin, H. Calkins, M. D. Ezekowitz, P. Gitman, A. S. Go, R. L. McNamara, J. V. Messer, J. L. Ritchie, S. J.W. Romeo, et al. ACC/AHA/Physician Consortium 2008 Clinical Performance Measures for Adults With Nonvalvular Atrial Fibrillation or Atrial Flutter: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and the Physician Consortium for Performance Improvement (Writing Committee to Develop Clinical Performance Measures for Atrial Fibrillation) Circulation, February 26, 2008; 117(8): 1101 - 1120. [Full Text] [PDF] |
||||
|
E. M. Hylek and D. E. Solarz Dual antiplatelet and oral anticoagulant therapy increasing use and precautions for a hazardous combination. J. Am. Coll. Cardiol. Intv., February 1, 2008; 1(1): 62 - 64. [Full Text] [PDF] |
||||
|
Writing Group Members, W. Rosamond, K. Flegal, K. Furie, A. Go, K. Greenlund, N. Haase, S. M. Hailpern, M. Ho, V. Howard, et al. Heart Disease and Stroke Statistics--2008 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation, January 29, 2008; 117(4): e25 - e146. [Full Text] [PDF] |
||||
|
L. Mont, D. Tamborero, R. Elosua, I. Molina, B. Coll-Vinent, M. Sitges, B. Vidal, A. Scalise, A. Tejeira, A. Berruezo, et al. Physical activity, height, and left atrial size are independent risk factors for lone atrial fibrillation in middle-aged healthy individuals Europace, January 4, 2008; (2008) eum263v1. [Abstract] [Full Text] [PDF] |
||||
|
A. G.G. Turpie New oral anticoagulants in atrial fibrillation Eur. Heart J., January 2, 2008; 29(2): 155 - 165. [Abstract] [Full Text] [PDF] |
||||
|
F. G. Cosio, E. Aliot, G. L. Botto, H. Heidbuchel, C. J. Geller, P. Kirchhof, J.-C. De Haro, R. Frank, J. P. Villacastin, J. Vijgen, et al. Delayed rhythm control of atrial fibrillation may be a cause of failure to prevent recurrences: reasons for change to active antiarrhythmic treatment at the time of the first detected episode Europace, January 1, 2008; 10(1): 21 - 27. [Abstract] [Full Text] [PDF] |
||||
|
J. E. Marine Catheter Ablation Therapy for Supraventricular Arrhythmias JAMA, December 19, 2007; 298(23): 2768 - 2778. [Abstract] [Full Text] [PDF] |
||||
|
H. M. Krumholz and F. A. Masoudi The Year in Epidemiology, Health Services Research, and Outcomes Research J. Am. Coll. Cardiol., December 4, 2007; 50(23): 2254 - 2262. [Full Text] [PDF] |
||||
|
D. G. Katritsis and A. J. Camm Catheter ablation of atrial fibrillation: do we know what we are doing? Europace, November 1, 2007; 9(11): 1002 - 1005. [Full Text] [PDF] |
||||
|
M. D. Ezekowitz Maintaining Sinus Rhythm -- Making Treatment Better Than the Disease N. Engl. J. Med., September 6, 2007; 357(10): 1039 - 1041. [Full Text] [PDF] |
||||
|
E. M. Hylek, C. Evans-Molina, C. Shea, L. E. Henault, and S. Regan Major Hemorrhage and Tolerability of Warfarin in the First Year of Therapy Among Elderly Patients With Atrial Fibrillation Circulation, May 29, 2007; 115(21): 2689 - 2696. [Abstract] [Full Text] [PDF] |
||||
|
G. Y H Lip, P. Kakar, and T. Watson Atrial fibrillation--the growing epidemic Heart, May 1, 2007; 93(5): 542 - 543. [Abstract] [Full Text] [PDF] |
||||
|
N. F Murphy, C. R Simpson, P. S Jhund, S. Stewart, M. Kirkpatrick, J. Chalmers, K. MacIntyre, and J. J V McMurray A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland Heart, May 1, 2007; 93(5): 606 - 612. [Abstract] [Full Text] [PDF] |
||||
|
P. Zimetbaum Amiodarone for Atrial Fibrillation N. Engl. J. Med., March 1, 2007; 356(9): 935 - 941. [Full Text] [PDF] |
||||
|
G. F. Mitchell, R. S. Vasan, M. J. Keyes, H. Parise, T. J. Wang, M. G. Larson, R. B. D'Agostino Sr, W. B. Kannel, D. Levy, and E. J. Benjamin Pulse Pressure and Risk of New-Onset Atrial Fibrillation JAMA, February 21, 2007; 297(7): 709 - 715. [Abstract] [Full Text] [PDF] |
||||
|
W. Rosamond, K. Flegal, G. Friday, K. Furie, A. Go, K. Greenlund, N. Haase, M. Ho, V. Howard, B. Kissela, et al. Heart Disease and Stroke Statistics--2007 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation, February 6, 2007; 115(5): e69 - e171. [Full Text] [PDF] |
||||
|
M. L. Weisfeldt and S. J. Zieman Advances In The Prevention And Treatment Of Cardiovascular Disease Health Aff., January 1, 2007; 26(1): 25 - 37. [Abstract] [Full Text] [PDF] |
||||
|
D. G. Wyse Transvenous Radiofrequency Catheter Ablation for Atrial Flutter and Atrial Fibrillation: The End of the Beginning? Circulation, October 17, 2006; 114(16): 1670 - 1672. [Full Text] [PDF] |
||||
|
AFib Incidence: How Fast Is It Increasing? Journal Watch Cardiology, September 13, 2006; 2006(913): 3 - 3. [Full Text] |
||||
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |